Palo Alto Investors LP Long-Term Concentrated

Location: Palo Alto, CA

CIK: 0001306923 · Show all filings

Period: Q4 2019 (← Previous) (Next →)

Filing Date: Apr 8, 2020

Total Value: $1.816B (100.0% shares, 0.0% debt)

Holdings (37)

BMRN BIOMARIN PHARMACEUTICAL INC 9.4%
Value $171M Shares 2,021,136 Share Price $84.55 * Est. Cost/Share $80.19 Unrealized @ Report Date -5.8%
INSM INSMED INC 9.0%
Value $164M Shares 6,848,760 Share Price $23.88 * Est. Cost/Share $17.16 Unrealized @ Report Date +18.5%
— EPIZYME INC 8.3%
Value $151M Shares 6,145,945 Share Price $24.60 Est. Cost/Share $15.12 Unrealized @ Report Date —
STAA STAAR SURGICAL CO 7.3%
Value $133M Shares 3,778,938 Share Price $35.17 * Est. Cost/Share $13.06 Unrealized @ Report Date +152.6%
— IMMUNOMEDICS INC 6.9%
Value $125M Shares 5,923,195 Share Price $21.16 Est. Cost/Share $13.38 Unrealized @ Report Date —
UTHR UNITED THERAPEUTICS CORP 6.3%
Value $114M Shares 1,288,902 Share Price $88.08 Est. Cost/Share $88.73 Unrealized @ Report Date -0.8%
— AIMMUNE THERAPEUTICS INC 6.2%
Value $113M Shares 3,380,441 Share Price $33.47 Est. Cost/Share $22.84 Unrealized @ Report Date —
— ABIOMED INC 5.3%
Value $96.24M Shares 564,168 Share Price $170.59 Est. Cost/Share $37.80 Unrealized @ Report Date —
— ALEXION PHARMACEUTICALS INC 5.2%
Value $94.97M Shares 878,100 Share Price $108.15 Est. Cost/Share $121.54 Unrealized @ Report Date —
— KARYOPHARM THERAPEUTICS INC 4.8%
Value $88.09M Shares 4,595,001 Share Price $19.17 Est. Cost/Share $17.42 Unrealized @ Report Date —
ACAD ACADIA PHARMACEUTICALS INC 4.5%
Value $81.51M Shares 1,905,374 Share Price $42.78 Est. Cost/Share $27.34 Unrealized @ Report Date +59.1%
— WRIGHT MEDICAL GROUP NV 4.1%
Value $75.07M Shares 2,463,055 Share Price $30.48 Est. Cost/Share $23.42 Unrealized @ Report Date —
VNDA VANDA PHARMACEUTICALS INC 4.1%
Value $74.26M Shares 4,525,476 Share Price $16.41 * Est. Cost/Share $11.21 Unrealized @ Report Date +34.9%
FOLD AMICUS THERAPEUTICS INC 4.0%
Value $72.21M Shares 7,413,920 Share Price $9.74 * Est. Cost/Share $7.59 Unrealized @ Report Date +20.5%
— CLOVIS ONCOLOGY INC 2.9%
Value $52.71M Shares 5,056,286 Share Price $10.43 Est. Cost/Share $48.59 Unrealized @ Report Date —
— SAGE THERAPEUTICS INC 2.6%
Value $47.18M Shares 653,594 Share Price $72.19 Est. Cost/Share $48.62 Unrealized @ Report Date —
— AMAG PHARMACEUTICALS INC 2.0%
Value $37.05M Shares 3,044,374 Share Price $12.17 Est. Cost/Share $29.07 Unrealized @ Report Date —
ALGN ALIGN TECHNOLOGY INC 2.0%
Value $35.58M Shares 127,505 Share Price $279.04 * Est. Cost/Share $114.31 Unrealized @ Report Date +118.1%
— MOMENTA PHARMACEUTICALS INC 1.8%
Value $33.25M Shares 1,685,372 Share Price $19.73 Est. Cost/Share $14.06 Unrealized @ Report Date —
PRTA PROTHENA CORP PLC 0.9%
Value $15.71M Shares 992,749 Share Price $15.83 * Est. Cost/Share $32.98 Unrealized @ Report Date -67.5%
PBYI PUMA BIOTECHNOLOGY INC 0.6%
Value $11.8M Shares 1,349,180 Share Price $8.75 * Est. Cost/Share $28.90 Unrealized @ Report Date -71.4%
— RIGEL PHARMACEUTICALS INC 0.4%
Value $7.581M Shares 3,542,551 Share Price $2.14 Est. Cost/Share $3.40 Unrealized @ Report Date —
— DICERNA PHARMACEUTICALS INC 0.4%
Value $7.31M Shares 331,813 Share Price $22.03 Est. Cost/Share $5.39 Unrealized @ Report Date —
KLDO KALEIDO BIOSCIENCES INC 0.2%
Value $3.956M Shares 787,999 Share Price $5.02 * Est. Cost/Share $13.76 Unrealized @ Report Date -53.8%
GILD GILEAD SCIENCES INC 0.1%
Value $2.554M Shares 39,300 Share Price $64.99 * Est. Cost/Share $62.02 Unrealized @ Report Date -17.3%
— ZOGENIX INC 0.1%
Value $1.538M Shares 29,500 Share Price $52.14 Est. Cost/Share $13.36 Unrealized @ Report Date —
— ALIMERA SCIENCES INC 0.1%
Value $1.523M Shares 200,919 Share Price $7.58 Est. Cost/Share $4.88 Unrealized @ Report Date —
— REVANCE THERAPEUTICS INC 0.1%
Value $1.438M Shares 88,590 Share Price $16.23 Est. Cost/Share $16.23 Unrealized @ Report Date —
CYTK CYTOKINETICS INC 0.1%
Value $1.312M Shares 123,686 Share Price $10.61 * Est. Cost/Share $6.71 Unrealized @ Report Date +53.0%
— INTRA-CELLULAR THERAPIES INC 0.1%
Value $1.283M Shares 37,400 Share Price $34.30 Est. Cost/Share $34.30 Unrealized @ Report Date —
ALDX ALDEYRA THERAPEUTICS INC 0.0%
Value $427K Shares 73,500 Share Price $5.81 Est. Cost/Share $7.53 Unrealized @ Report Date -23.3%
— SUNESIS PHARMACEUTICALS INC 0.0%
Value $393K Shares 1,162,473 Share Price $0.34 Est. Cost/Share $4.37 Unrealized @ Report Date —
— MARINUS PHARMACEUTICALS INC 0.0%
Value $271K Shares 125,321 Share Price $2.16 Est. Cost/Share $4.17 Unrealized @ Report Date —
— MINERVA NEUROSCIENCES INC 0.0%
Value $258K Shares 36,319 Share Price $7.10 Est. Cost/Share $5.62 Unrealized @ Report Date —
— IDERA PHARMACEUTICALS INC 0.0%
Value $140K Shares 77,044 Share Price $1.82 Est. Cost/Share $8.90 Unrealized @ Report Date —
— SOPHIRIS BIO INC 0.0%
Value $91,000 Shares 247,000 Share Price $0.37 Est. Cost/Share $2.60 Unrealized @ Report Date —
— MELINTA THERAPEUTICS INC 0.0%
Value $5,000 Shares 10,137 Share Price $0.49 Est. Cost/Share $3.55 Unrealized @ Report Date —